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Genome-wide association meta-analysis of corneal curvature identifies novel loci and 1 
shared genetic influences across axial length and refractive error 2 
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Corneal curvature, a highly heritable trait, is a key clinical endophenotype for myopia - a 115 
major cause of visual impairment and blindness in the world. Here we present a trans-ethnic 116 
meta-analysis of corneal curvature GWAS in 44,042 individuals of Caucasian and Asian with 117 
replication in 88,218 UK Biobank data. We identified 47 loci (of which 26 are novel), 118 
with population-specific signals as well as shared signals across ethnicities. Some identified 119 
variants showed precise scaling in corneal curvature and eye elongation (i.e. axial length) to 120 
maintain eyes in emmetropia (i.e. HDAC11/FBLN2 rs2630445, RBP3 rs11204213); others 121 
exhibited association with myopia with little pleiotropic effects on eye elongation. Implicated 122 
genes are involved in extracellular matrix organization, developmental process for body and 123 
eye, connective tissue cartilage and glycosylation protein activities. Our study provides 124 
insights into population-specific novel genes for corneal curvature, and their pleiotropic 125 
effect in regulating eye size or conferring susceptibility to myopia. 126 
 127 




Refractive error is common worldwide and particularly so in Asia, where uncorrected 130 
refractive error is one of the major causes of visual impairment and blindness1,2.  In 2015, 131 
uncorrected refractive error caused moderate or severe visual impairment in 116 million 132 
people, and blindness in 7.4 million people - these figures are expected to rise to 128 million 133 
and 8.0 million, respectively, by 20203. Thus there is a critical need to better understand the 134 
genetic basis of how different optical components may contribute to ammetropia, for which 135 
corneal curvature represents a main endophenotype.  136 
 137 
Corneal curvature (CC) is a key clinical endophenotype for the refractive status of the eye. 138 
The corneal air-tissue interface provides approximately two-thirds of the eye’s optical 139 
power4. Thus, changes in the CC significantly affect refractive error, such as myopia. A 140 
steeper CC was associated with a more negative/myopic refractive error. In the emmetropic 141 
eye, the refractive power of the eye’s optical components (such as CC) must be appropriate to 142 
its axial length (AL). If the changes in CC, AL or other ocular components such as lens 143 
thickness or anterior chamber depth are not aligned, refractive errors (myopia or hyperopia) 144 
are likely to occur. 145 
 146 
Clinically, CC associates with ethnicity5,6, age7, and anthropometric features (height and 147 
weight)7. Based on family and twin studies, CC is highly heritable, with 35% to 95% of inter-148 
individual CC variation attributed to genetic factors8-12. Previous genome-wide association 149 
studies (GWASs) have been successful in identifying more than 160 loci associated with 150 
refractive error13-15, and nine loci associated with AL16. Only four loci associated with CC 151 
have been previously reported from GWAS analyses: MTOR 17, CMPK118 and RBP318 152 
identified in Asians, and PDGFRA in both Asians17 and Europeans19,20. A further 31 loci in 153 
European emmetropes, accounting for an additional 2.3% of variance in CC, have also been 154 
provisionally reported21. Associated variants identified to date cannot fully explain the 155 
additive genetic variance of CC, and hence other genetic variants are likely to contribute to 156 
this endophenotype. The difference in the prevalence of myopia in various ethnic groups, 157 
particularly in Asia, also suggests that certain CC-associated alleles may be population-158 
specific19. Furthermore, the extent to which shared or distinct genetic loci contribute to 159 




Thus, we conducted the largest GWAS meta-analysis of CC to date, incorporating both 162 
European and Asian cohorts in a single analysis from the Consortium for Refractive Error 163 
and Myopia (CREAM) and validated our findings in the United Kingdom (UK) Biobank. 164 
 165 
RESULTS 166 
Primary GWAS of corneal curvature 167 
The CREAM discovery cohorts included 29,580 individuals with European ancestry from 18 168 
studies, and 14,462 individuals with Asian ancestry from 10 studies. The demographics of 169 
these 44,042 participants are shown in Supplementary Table 1. GWAS analyses for CC 170 
were performed at the cohort level for all variants genotyped or imputed using the 1000 171 
Genomes Project data as reference panels7 (Supplementary Table 2). The genomic control 172 
inflation factor (λGC: 0.872 to 1.085) showed little evidence of inflation in test statistics at the 173 
study level. 174 
 175 
We applied a uniform set of quality-control procedures to all cohort-level GWAS results in 176 
CREAM and meta-analysed up to 8.94 million variants (see Methods). For the discovery 177 
phase, we performed an inverse variance-weighted meta-analysis on the European and Asian 178 
populations. The quantile-quantile plot for the trans-ethnic meta-analysis (λGC: 1.119; 179 
Supplementary Figure 1) indicated moderate inflation, and genomic control-adjusted test 180 
statistics were generated. The inflation is partially due to polygenicity as the linkage 181 
disequilibrium (LD)-score regression intercepts were close to one22 (LD-score regression 182 
intercept of 1.045 in Europeans and 1.013 in Asians).  183 
 184 
Figure 1 shows the Manhattan plot for the trans-ethnic meta-analysis for CC. We identified 185 
41 loci at genome-wide significance (P <5.0 x 10−8; Table 1; Supplementary Figure 2 - 4). 186 
We performed replication analyses of these loci for CC in 88,218 participants with European 187 
ancestry from the UK Biobank. Thirty-seven (90.2%) of the 41 lead variants passed genome-188 
wide significance in the UK Biobank data (Table 1). The signals of the two loci 189 
(CMPK1/STIL, RBP3) not reaching genome-wide significance in the replication phase were 190 
mainly driven by the CREAM Asian populations. In the combined CREAM and UK Biobank 191 
meta-analysis, the five most strongly associated loci were RSPO1 (rs4074961; P = 6.51 x 10-192 
100), HUS1 (rs12702376; P = 2.77 x 10-86), FGF9 (rs9506725; P = 1.21 x 10
-78), PDGFRA 193 
(rs1800813; P = 1.59 x 10
-73) and HDAC11/FBLN2 (rs2630445; P = 4.92 x 10-67). The 194 
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RSPO1 gene was previously identified as the strongest locus with the same lead SNP 195 
rs4074961 associated with AL in CREAM23. Here it stands out as the most significant locus 196 
for CC in our large meta-analysis. We confirmed associations with CC in the four previously 197 
identified loci in our samples: PDGFRA, MTOR, RBP3 and CMPK117-20, and in an additional 198 
17 loci provisionally identified in the European emmetropes from the UK Biobank21. In total, 199 
we identified 20 novel CC loci through single-variant analysis.  200 
 201 
Following the age classification scheme adopted by the CREAM consortium, we stratified 202 
the CREAM samples into younger (age < 25 years) and older (age ≥ 25 years) groups. In the 203 
older group (n = 35,442), the top five genome-wide significant loci were RSPO1, MTOR, 204 
PDGFRA1, HUS1 and FGF9 (Supplementary Data 1 ). There were no novel genome-wide 205 
significant hits for CC in both groups. No variants reached genome-wide significance in the 206 
younger group (n = 8,620), likely due to the insufficient power in contrast to the older group. 207 
The effect sizes and directions of effect for the top variants were consistent between the 208 
younger and older groups.  209 
 210 
Trans-ethnic comparison of genotypic effects in Europeans versus Asians 211 
Among the 41 lead variants identified in the full discovery samples, the effect size and 212 
direction of effect were largely consistent across Europeans and Asians (Table 1). To 213 
evaluate whether genetic effect sizes were consistent in Europeans versus Asians in the 214 
CREAM samples, we compared additive effect sizes (beta coefficient in millimetre per allele) 215 
of variants with p-value < 0.01 in both populations. We grouped these variants by inter-216 
population allele frequency discrepancy between the two ancestry groups (< 0.1, 0.1- 0.3, and 217 
> 0.3). Overall, the variants were concordant in direction of effects and effect sizes (Figure 218 
2; a-c). The effect sizes appeared most consistent in variants with little discrepancy in allele 219 
frequency (2a; allele frequency difference < 0.1), and less consistent in variants of larger 220 
allele frequency discrepancy (2c; allele frequency difference > 0.3).  221 
 222 
The high concordance of genetic effects between Europeans and Asians, however, could not 223 
rule out the possibility of discrepancy at some loci with large inter-population differences in 224 
the allele frequency and LD structure. Three loci in our all-ancestry analyses were driven by 225 
European populations (HDAC11/FBLN2 rs2630445, ADAMTS19/CASY3 rs7708378, and 226 
FGF9 rs9506725), and two loci were driven by Asian populations (RBP3 rs11204213 and 227 
CMPK1/STIL rs60078183). In the ethnic group (either the Asian or European populations) 228 
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where these variants were not associated, they typically presented as monomorphic in the 229 
other ethnic group, as well as those variants in LD with the lead variant (r2 ≥ 0.8; 230 
Supplementary Data 2). Regional plots at HDAC11/FBLN2 rs2630445, CMPK1/STIL 231 
rs60078183 and FGF9 rs9506725 were presented in Europeans (Figure 2 d, e & f) and 232 
Asians (Figure 2 g, h & i) respectively, with inter-population allele frequency at 0.10, 0.20 233 
and 0.36. The proxy SNPs adjacent showed minimal significance at only two loci in Asians 234 
(HDAC11/FBLN2 rs2655225, P = 3.34 x10-3, r2 = 0.62) and ADAMTS19/CASY3 rs11746536; 235 
P = 2.67 x 10-4, r2= 0.11; Supplementary Table 3). For GWAS analyses performed 236 
separately in Europeans and Asians, there were two Asian-specific loci (EMX2/EMX2OS 237 
rs2240776, P = 2.45 x 10-8; NCAPG rs7672919, P = 3.90 x 10-8; Supplementary Table 4); 238 
both did not reach genome-wide significance in the combined analysis. In addition, one locus 239 
showing suggestive significance in CREAM Europeans (PIEZO2 rs2101976; P =7.32 x 10-8) 240 
has been replicated in the UK Biobank data (P = 8.90 x 10-14). 241 
 242 
We calculated SNP-heritability (SNP-h2) using GWAS summary statistics24. The SNP-h2 243 
estimate for CC in Asians (0.196, s.e. = 0.036) was numerically lower than in Europeans 244 
(0.267, s.e.= 0.024), but there was no statistical evidence for a meaningful difference. A 245 
similar pattern was noted in a previous study12.  246 
 247 
Association of corneal curvature loci with spherical equivalent and axial length  248 
In further analyses, we assessed the associations of the 41 CC lead variants with spherical 249 
equivalent15,25 in 95,505 participants from the UK Biobank, as well as in a subset of CREAM 250 
participants with AL measurement (N = 10,851; Supplementary Table 5). The lead variants 251 
were categorized into the following three groups using false discovery rates (FDR) set at a 252 
threshold of 1% from the Benjamini-Hochberg procedure26 (Figure 3 and Supplementary 253 
Data 3).  254 
 255 
Eight CC variants were associated with AL, but not spherical equivalent (Group A, Figure 256 
3). That is, the effect allele of the variant was associated with eye size, e.g. a larger eye with 257 
both a flatter CC and longer AL (positive genetic effects on both CC and AL; bar in red, 258 
Figure 3) or a smaller eye with both a steeper CC and shorter AL (negative genetic effects; 259 
bar in blue), but was not associated with spherical equivalent.  For instance, HMGA2 260 
rs7959830 T allele was associated with a steeper CC (β = -0.018, s.e. = 0.002, P = 3.02 x 10-261 
16) and shorter AL (β = -0.047, s.e. = 0.014, P = 6.54 x 10-4), but not spherical equivalent (β = 262 
9 
 
0.005, s.e. = 0.013, P = 0.670). A lack of association with refractive error at these variants 263 
might be explained on the basis of the compensatory effects resulting in, a steeper CC (that 264 
tends to make the eye more myopic) and shorter AL (that tends to make the eye more 265 
hyperopic/less myopic), or a flatter CC and longer AL The compensatory genetic effects for 266 
CC and AL relevant to the effects on myopia or hyperopia is illustrated in Figure 4. Among 267 
these variants, the pleiotropic association on AL of HDAC11/FBLN2 rs2630445, 268 
ADAMTS19/CHSY rs7708378 were mainly driven from European populations, and RBP3 269 
rs11204213 from Asian populations.  270 
 271 
Fifteen CC variants were associated with spherical equivalent (Group B, Figure 3). Eleven of 272 
these variants were not associated with AL. The strongest signals associated with spherical 273 
equivalent (P < 1 x 10-7) were CASC15 rs9366426, CHRND/PRSS56 rs2245601, KAZALD1 274 
rs807037, FBN1 rs9806595, and RNLS rs166976. Among these 11 variants, the allele 275 
associated with a steeper CC was associated with a more negative/myopic refractive error (or 276 
a flatter CC and more positive/hyperopic refractive error). For instance, FBN1 rs9806595 T 277 
allele was associated with a steeper CC (β = -0.012, s.e. = 0.002, P = 2.23 x 10-8) and more 278 
myopic refractive error (β = -0.084, s.e. = 0.014, P = 1.40 x 10-8), but not AL (β = -0.015, s.e 279 
= 0.013, P = 0.231). For the remaining CC variants at four loci that were associated spherical 280 
equivalent as well as AL (HUS1, RP11-91P17.1, FGF9 and IGFBP5/TNP1), the direction of 281 
genetic effect on spherical equivalent may depend on the relative magnitude of effect on CC 282 
versus AL. For instance, although both HUS1 rs12702376 C allele and RP11-91P17.1 283 
rs7004112 T allele were associated with steeper CC (that tends to make the eye more 284 
myopic) and shorter AL (that tends to make the eye less myopic), HUS1 was associated with 285 
a negative/myopic refractive error, whilst RP11-91P17.1 was associated with a 286 
positive/hyperopic refractive error. Among these variants, pleiotropic effects of FGF9 287 
rs9506725 were mainly driven from European populations.  288 
 289 
The remaining 18 CC variants (Group C, Figure 3) were not associated with spherical 290 
equivalent or AL at FDR >1%. The association on CC and spherical equivalent at the 291 
majority loci was, although not significant, in an expected direction, e.g. with a steeper CC 292 
and a more negative/myopic refractive error (or vice versa). Among these variants, 293 
CMPK1/STIL rs60078183 was mainly driven by Asian populations. The pleiotropic genetic 294 
effects on spherical equivalent of CC-associated variants, together with previously implicated 295 




The pleiotropic effect ratio 
βAL
βCC was meta-analyzed across all variants in each group (Figure 4; 298 
Supplementary Table 6). The pleiotropic ratio 
βAL
βCC		in group A (2.92, 95% CI: 2.37-3.48) was 299 
larger than that in group B (1.66, 95% CI: 1.16 -2.16) and C (1.19, 95% CI:  0.78-1.61), with 300 
p-value at 7.56 x 10-4 and 1.68 x 10-6, respectively. For variants in group A, the pleiotropic 301 
effect for AL could offset genetic effect for CC towards myopia or hyperopia; namely, a 302 
genetically determined 1 mm increase (or decrease) for CC accompanied by a 2.92 mm 303 
increase (or decrease) on average for AL might cancel out their respective opposite effects on 304 
refractive error. In contrast, if the pleiotropic effects on AL could not compensate effects on 305 
CC, as shown in Group B, these variants may influence refractive error primarily through the 306 
net effect of CC. The interplay between AL, CC and refractive error at the variants in Group 307 
C is less clear, likely these variants might have pleiotropic effect for other endophenotypes, 308 
besides AL, to account for the genetic effects of CC on refractive error. 309 
 310 
Post GWAS gene-based and pathway analyses 311 
We applied gene-based tests using the Versatile Gene-based Association Study 312 
(VEGAS)28,29, with Bonferroni corrected p-value at 2.09 x 10-6 to test 24,000 genes for 313 
significance. Over and above the loci found in the per-variant tests, six additional genomic 314 
regions were significantly associated with CC via gene-based tests (Supplementary Table 315 
7): ANKRD65 (P = 9.0 x 10-7), PEAR1 (P = 1.57 x 10-7), ASB1 (P = 2.54 x 10-7), GMDS (P = 316 
2.48 x 10-8), EMX2OS (P = 4.84 x 10-8), and HM13-AS1 (P = 2.18 x 10-7).  317 
 318 
We further conducted gene set analysis using VEGAS by testing whether CC genes shared a 319 
common function or operated in the same pathways (see Methods). Thirty pathways were 320 
identified at Bonferroni corrected p-value of 5.14 x 10-6 (Supplementary Data 4), with those 321 
involving proteinaceous extracellular matrix (ECM) (GO: 0005578; P = 1.05 x 10-9) and 322 
ECM (GO: 0031012, P = 7.53 x 10-9) being the top two. The other significant pathways 323 
included gene sets involved in eye development (GO:0001654; P = 4.00 x 10-7) and camera-324 
type eye development, GO: 0043010, P = 3.20 x 10-6), as well as those involving in organ 325 
morphogenesis (GO:0009887; P = 4.86 x 10-7 ), skeletal system development (GO:0001501; 326 
P = 5.25 x 10-7) and the Wnt signalling pathway (KEGG:04310, P = 2.09 x 10-6). For the top 327 
41 loci identified in this study plus genes previously reported for CC (WNT7B27 and 328 
ZNRF316), we conducted gene set analysis using g: Profiler 329 
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(https://biit.cs.ut.ee/gprofiler/gost) and identified 48 significant pathways at multiple testing 330 
corrected p-value of 0.05. Among these, collagen-containing ECM (GO: 0062023; P = 2.72 x 331 
10-7) and ECM (GO: 0031012; P = 6.51 x 10-6) were the most significant terms 332 
(Supplementary Data 5). Other significant pathways consisted of heparin binding (GO: 333 
0062023; P = 6.95 x 10-5), embryonic morphogenesis (GO: 0048598; P = 3.99 x 10-4), 334 
glycosaminoglycan binding (GO: 0005539, P = 6.86 x 10-4), and skeletal system 335 
development (GO: 0001501; P = 1.11 x 10-3) etc. 336 
 337 
To visualize functional enrichment of identified gene sets, we mapped these sets graphically 338 
into an enrichment network30 in Cytoscape31. Similarity coefficients greater than 0.375 339 
were used to place these sets together with the interconnectivity drawn by a line. Using 340 
comprehensive collections of gene sets related to CC, we identified enrichments in gene 341 
sets involved in organism development and growth, with components for eye development 342 
and connective tissue cartilage, explicitly suggesting a strong genetic link between the size 343 
of the eye and organism/body (Figure 5). We also observed that gene sets were involved in 344 
ECM and glycosylation protein activity, which have previously been suggested in 345 
pathways related to central corneal thickness32.  346 
 347 
To assess any specific roles of subset of CC genes with pleiotropic effects on myopia, we 348 
performed gene set clustering. Enriched pathways identified included basement membrane, 349 
endoplasmic reticulum lumen, collagen-containing extracellular matrix, ossification, and 350 
osteoblast differentiation (Figure 5; Diamond node; Supplementary Data 5). The pathways 351 
were closely connected to ECM or developmental process, thus underlying a functional 352 
heterogeneity in genes exhibiting pleiotropic effects on both CC and refractive error.  353 
 354 
Additional pathways identified from the whole genome data using VEGAS, such as elastic 355 
fibre formation, camera-type eye development and O-linked Glycosylation, also displayed 356 
connectivity to the ECM, development processes and glycosylation protein activity (Figure 357 
5; nodes in green). A few pathways (regulation of stem cell differentiation, system 358 
development, etc.) failed to link to any existing gene sets were identified; this is likely 359 
attributable to marginal and uncharacterized CC-genes.  360 
 361 
Biological function of the CC-associated loci  362 
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We examined gene expression in 20 normal human donor eyes from the ocular tissue 363 
database (OTDB; https://genome.uiowa.edu/otdb/). The majority of the genes identified at the 364 
41 loci were expressed in human ocular tissues including cornea, sclera, ciliary body or lens 365 
etc. (Supplementary Data 6). THBS4 had the highest expression in the cornea and sclera, 366 
IGFBP5 in the ciliary body and sclera, and PDGFRA in the lens.   367 
 368 
We also queried expression quantitative trait loci (e-QTL) database to assess the association 369 
between the gene expression and the top CC-variants in different human tissues (see UTLs). 370 
Twenty-one index variants were eQTLs for the expression of genes, which resided in, or 371 
were adjacent to, the variant (Supplementary Data 7). Among them, the majority of 372 
variants were eQTL’s for the expression of the nearest gene. There are some exceptions. For 373 
example, SNP rs807037 is a missense variant within the KAZALD1 gene and is also an eQTL 374 
for the nearby gene SFXN3 in artery, brain, adipose subcutaneous and nerve tissues (P < 2.20 375 
x 10-5). Intronic MTOR rs3737611 is an eQTL for EXOSC10 in thyroid, nerve and artery 376 
tissues (P < 5.70 x 10-5). Intronic RSPO1 rs4074961 is an eQTL for itself and nearby genes 377 
GNL2, DNALI1 and MEAF6 in various tissues. 378 
 379 
The newly identified genes are largely involved in ocular growth/development. LMX1B 380 
(encoding a LIM homeodomain class transcription factor) regulates anterior segment 381 
morphogenesis and patterning33, and is associated with Nail-Patella syndrome34. Recently, 382 
LMX1B has been reported to be associated with primary open-angle glaucoma, accompanied 383 
by development defects of the ocular anterior segments including cornea35-37. SOX2 384 
(encoding a member of the SRY-related HMG-box family of transcription factors) links to 385 
both anophthalmia and microphthalmia38. Other CC genes that are also associated with eye or 386 
overall morphology include GHSR (associated with craniofacial development39), HMGA2 387 
(linked to body height) and LCORL (linked to skeletal trunk height40).   388 
 389 
Five of  the implicated genes (ADAMTS3, ADAMTS6, ADAMTS7, ADAMTS19, and 390 
ADAMTS20) belong to the ADAMTS protein family, which is closely involved in regulating 391 
the organization and function of ECM41. For instance, ADAMTS6 has a major role in focal 392 
adhesion and tight junction formation, and can alter the deposition of fibrillin microfibrils in 393 
epithelial cells42. Interestingly, ADAMTS family members also associate with height 394 
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variation (ADAM28, ADAMTS19, ADAMTS2, ADAMTS3, ADAMTS6, ADAMTSL1, 395 
ADAMTSL3), suggesting their pleiotropic roles in body growth43.  396 
 397 
A cluster of novel genes are involved in both ECM and organism/eye development. For 398 
instance, FBN1 encodes the ECM protein fibulin-1, which modulates corneal cell migration 399 
by interactions with other ECM components, such as fibronectin44. Weill-Marchesani 400 
syndrome (that may be associated with thicker and steeper corneas) may also result from 401 
dominant mutations in FBN1. Fibronectin and IGFBP5 also bind to each other. This binding 402 
regulates the ligand-dependent action of IGFBP5 on insulin-like growth factors, and this has 403 
effects on cell proliferation, differentiation, survival, and motility. IGFBP5 shows expression 404 
in the human cornea and was down regulated in eyes with keratoconus45,46. BMP7 encodes a 405 
member of the transforming growth factor -β superfamily that is involved in numerous 406 
cellular functions including development, morphogenesis, cell proliferation, apoptosis, and 407 
ECM synthesis47. BMP7 is key in eye development during embryogenesis, and BMP7-408 
knockout mice have been shown to develop anophthalmia48,49. OFCC1 (encoding a reticular 409 
cytoplasmic protein expressed during embryonic development) in the Medaka fish is 410 
associated with the ojoplano (‘flat eye’) phenotype due to defective eye cup morphogenesis50. 411 
COL5A1 and COL6A1 encode components of type V and VI fibrillar collagens that are 412 
present in the human cornea51. COL6A1, together with ADAMTS20, have been reported to be 413 
associated with intraocular pressure52. COL5A1 mutations are found in classical Ehlers-414 
Danlos Syndrome53 which is associated with thinner and steeper corneas54.  COL5A1 is also a 415 
susceptibility locus for central corneal thickness55,56. THBS4 encodes an extracellular calcium 416 
binding protein that is involved in cell proliferation, adhesion, and migration57. FGF9  is 417 
involved in the neural patterning of the optic neuroepithelium58. 418 
 419 
Genes identified as being involved in the Wnt signaling pathway were also implicated in our 420 
analysis (SOX2, FRAT1, FRAT2, RSPO1, FGF9; Supplementary Data 5 “canonical Wnt 421 
signaling pathway”). Two additional Wnt signalling related genes (ZNRF316and WNT7B27), 422 
though not the top genes in this study, were also identified as being associated with CC or 423 
axial length. The Wnt signalling pathway has prominent effects on multiple developmental 424 
events during embryogenesis59, including that of differentiation of the anterior segment of the 425 
eye60,61, and retinal development62,63. 426 
 427 
DISCUSSION  428 
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In the largest CREAM trans-ethnic GWAS meta-analysis of CC to date (44,042 individuals 429 
with replication in 88,218 participants from UK Biobank), we identified novel loci through 430 
single-variant analysis, and gene-based tests. SNP-heritability was estimated at 0.267 and 431 
0.196 in Europeans and Asians, respectively. We discovered population-specific loci that 432 
existed in both European and Asian ethnic groups, as well as the presence of a high 433 
concordance of inter-population genetic effects overall. Variants were involved in 434 
coordinating eye size (by affecting CC and AL concurrently) whilst maintaining emmetropia 435 
(Group A). Meanwhile, other genetic variants were associated with refractive error (Group 436 
B); the genetic effect for AL could not compensate the effect for CC, as showing that the 437 
pleiotropic effect ratio 
βAL
βCC was significant smaller than that of  “eye size” variants. A third 438 
group of variants was also observed that appeared independent in terms of pleiotropic effects. 439 
Besides pathways related to the ECM, the implicated genes were significantly enriched in 440 
pathways involved in organism development and growth, eye development, connective tissue 441 
cartilage and glycosylation protein activity. Implicated genes with pleiotropic effects on 442 
refractive error were involved in diverse pathways related to ECM and organism 443 
development and growth.  444 
 445 
Our data provide insights into novel genes that regulate CC across European and Asian 446 
populations. We found trans-ethnic replication of significant loci, and a high concordance of 447 
genetic effects in variants with little discrepancy in allele frequency between the two ancestry 448 
groups. Our results are robust as 90.2% of CC-associated loci were replicated at a genome-449 
wide significance throughout the UK Biobank. We also confirm the association of the MTOR 450 
loci17 with CC in Europeans, in contrast to the lack of replication in previous Europeans 451 
studies with much smaller sample size19,20. Although the underlying genetic effects were 452 
largely shared between the two ancestry groups, at the same time, population-specific loci 453 
were also observed: HDAC11/FBLN2, ADAMTS19/CHSY3 and FGF9 in Europeans, and 454 
RBP3 and CMPK1/STIL previously reported in Asians18. In these cases, the lead variants 455 
were monomorphic in the other non-significant Asian or European populations respectively, 456 
and any signals barely seen from the flanking variants at these loci. Our data show that the 457 
trans-ethnic meta-analysis approach yields shared and unique variants for CC in Europeans 458 




We used bioinformatics tools to demonstrate the functional connectivity between the 461 
associated genes. The newly identified loci such as LMX1B, SOX2, NHSL1, GHSR, HMGA2, 462 
IGFBP5, FRAT1, FRAT2, STIL, USP1, HUS1, STON2, and IGF2 are mainly involved in 463 
organism growth and eye development. Additional notable CC candidate genes belong to the 464 
ADAMTS family, including ADAMTS7, ADAMTS19 and ADAMTS20 involved in 465 
organization and function of ECM. Novel genes such as FBN1, BMP7, COL6A1, THBS4, 466 
FBLN2, and KAZALD1 are involved in both ECM formation and organism development. In 467 
addition, CC-genes associated with refractive error were involved in basement membrane, 468 
endoplasmic reticulum lumen, collagen-containing extracellular matrix, ossification and 469 
osteoblast differentiation, underlying a functional heterogeneity in genes exhibiting 470 
pleiotropic effects on both CC and refractive error.  471 
  472 
Our study is the most comprehensive study on pleiotropic effects of CC-associated genes on 473 
eye size and refractive error in humans. Several small-size studies also have reported the 474 
effects of “eye-size’ genes, such as PDGFRA17,19,20  and RBP318. Our study confirmed 475 
previous findings. Studies in mice and chicken also support the existence of distinctive 476 
genetic effects to determine eye sizes, for instance, 1) effects that purely govern eye size, 2) 477 
effects restricted to specific ocular dimension (i.e. CC or AL separately) or 3) effects that 478 
scale the size of the eye and body simultaneously64,65. Clearly, CC-genes are involved in 479 
heterogeneous genetic function. 480 
 481 
In human emmetropic eyes, CC is highly correlated with AL, and the two are carefully scaled 482 
relative to each other66. Thus, genetic pathways may exist to simultaneously influence AL 483 
and CC whilst maintaining the emmetropic status12,64,67. In our analyses, we have therefore 484 
compared our set of CC loci with their respective associations with AL and refractive error. 485 
We identified ‘eye-size’ genes (HMGA2, RSPO1, HDAC11/FBLN2, RBP3, PDGFRA, 486 
NHSL1 and ADAMTS19/CHSY3 and INTS6) that were associated with eye size (e.g. a larger 487 
eye with both a flatter CC and longer AL, or vice versa), but not refractive error. The 488 
compensatory pleiotropic effect for AL could offset CC’s effect toward myopia or hyperopia; 489 
namely, a genetic determined 1 mm increase (or decrease) for CC accompanying a 2.92 mm 490 
increase (or decrease) on average for AL might cancel out their opposite effects on refractive 491 
error. This may represent a carefully coordinated scaling of optical components to maintain 492 
the eye in an emmetropic state as it grows. These genetic variants may therefore control 493 
variation in eye size independent of refractive error. Among these ‘eye-size’ genes, HMGA2 494 
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and HDAC11/FBLN2 are likely to have pleiotropic effects on both the coordinated scaling of 495 
the eye, as well as height68,69. Similarly, the ADAMTS19 gene encodes metalloproteinases 496 
that belong to the ADAMTS family with the members as human growth genes43. This is 497 
consistent with the findings that height (body size) and eye size are genetically 498 
coordinated12,70. Among the other ‘eye-size’ genes identified, some had roles in Wnt 499 
signalling (RSPO1 and HDAC11), platelet-derived growth factor signalling (PDGFRA), and 500 
extracellular ligands and calcium binding (FBLN2).  501 
 502 
In contrast to the group of ‘eye-size’ genes that do not affect spherical equivalent, there is 503 
another group of CC-implicated variants associated with refractive error, with little or no 504 
pleiotropic effect on AL (Group B). The pleiotropic ratio 
βAL
βCC	was significantly smaller than 505 
that in ‘eye-size’ variants, therefore, without adequate compensatory effects on AL, these 506 
variants may influence the refractive error status of the eye primarily through CC. There is 507 
one exception at loci RP11-91P17.1. Variant rs7000412 T allele was associated with steeper 508 
CC (that tends to make the eye more myopic) and shorter AL (less myopic) with overall 509 
effects towards to a hyperopic refractive error; thus this variant influenced refractive error 510 
likely through AL. Five top loci replicated in UK Biobank for refractive error (P < 1 x 10-7), 511 
including CHRND/RPSS56, FBN1, CASC15, RNLS and KAZALD1, have also been reported 512 
in previous CREAM GWAS13. Ten loci showed significance in replication after accounting 513 
for multiple testing (FDR <0.01). These genes are actively involved in pathways of basement 514 
membrane, endoplasmic reticulum lumen and collagen-containing extracellular matrix, 515 
linking to ECM and organism development, growth. Plotnikov et al recently also proposed a 516 
genetic link between CC and refractive error in Europeans71. Using CC-associated SNPs in 517 
emmetropes as instrument variables, they estimated the causal effect of CC on refractive 518 
error to be +1.41 D (95% CI, 0.65 to 2.16) less myopic refractive error per mm flatter cornea. 519 
A significant group of CC-genes identified in our study showing association with spherical 520 
equivalent corroborates the finding of an association between CC and refractive error.   521 
 522 
The remaining CC loci (Group C) were not significantly associated with refractive error or 523 
AL. However, in a majority of these variants, the associations with spherical equivalent, 524 
although not statistically significant, were in the expected direction—for instance, a flatter 525 
cornea and a more hyperopic spherical equivalent, or vice versa. It is unknown whether these 526 
loci may also have modulatory effects on other refractive components of the eye (e.g. lens 527 
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thickness or anterior chamber depth) that may have attenuated its effect on refractive error. In 528 
addition, some of these genes in Group 3 (FNDC3B ,COL5A1, COL6A1), together with genes 529 
in Group 2 (IGFBP5, FGF9, and CWC27/ADAMT6) was linked to connective tissue disorder 530 
(Supplementary Figure 6) and has been associated with keratoconus72-76, a disorder of 531 
corneal thinning and steepening, implying a possible effect of CC genes regulating refractive 532 
error and keratoconus.     533 
 534 
In summary, we have identified 47 genome-wide significant loci for CC (of which 26 are 535 
new), through a large-scale tans-ethnic GWAS meta-analysis. The importance of undertaking 536 
this study in individuals of different ethnicities cannot be understated as we identified both 537 
population-specific loci in Europeans as well as Asians as well as loci that were common 538 
between both ethnicities. These findings provide insights into the underlying genetic 539 
aetiology of eye growth and may provide pointers for us to explore why myopia is more 540 
prevalent in Asians than Europeans. These CC loci can coordinate AL and eye-size to keep 541 
human eyes emmetropic, and some play a role in the development of refractive errors 542 
primarily through variations in CC. Implicated genes were significantly enriched in a network 543 
linking extracellular matrix organization, developmental process for body and eye and 544 
glycosylation protein activities. Elucidating and characterising the heterogeneity of such 545 
genes that regulate the optical component dimensions of the eye may enable a better 546 




Study populations  549 
The discovery cohorts included 29,580 individuals with European ancestry from 18 studies, 550 
and 14,464 with Asian ancestry from 10 studies. General methods, demographics, and 551 
phenotyping of the study cohorts have previously been extensively described, and are 552 
provided in brief in Supplementary Table 1 and Supplementary Notes. In the replication 553 
phase, 88,218 participants of European ancestry from the UK Biobank who had 554 
measurements for CC were included in the replication stage, as well as 95,505 participants of 555 
European ancestry (from the UK Biobank) with phenotype information for refractive error 3. 556 
Written informed consent was obtained from all participants in accordance with the 557 
Declaration of Helsinki. All studies were performed with the approval of their local Human 558 
Research and Ethics Committee.   559 
 560 
Phenotype measurements  561 
All participating CREAM cohorts used similar protocols for the collection of keratometry 562 
and other ocular biometric measurements. The protocols have been described in detail 563 
elsewhere16,25,62. In brief, CC radii in the horizontal and vertical meridians were measured 564 
using an autokeratometer. The means (in millimetre) of CC from the individuals’ two eyes 565 
were used for analysis, while the means of the readings from one eye were used when the 566 
readings from the other eye were unavailable. Participants were excluded if they had corneal 567 
scars, keratoconus, prior refractive or cataract surgery, or other intraocular procedures that 568 
could alter CC. For the UK Biobank, participants were excluded from the analyses if they had 569 
an eye disorder that may have altered their refractive error or CC (see Supplementary 570 
Notes).     571 
 572 
Genotyping and imputation  573 
The CREAM study samples were genotyped on either Illumina or Affymetrix platforms. 574 
Genotypes were imputed using the 1000G Genomes Project reference panel (Phase I version 575 
3, March 2012 release). SNPs with low imputation quality were filtered using metrics 576 
specific to the imputation method and thresholds used in previous GWAS analyses. The 577 
Markov Chain Haplotyping software, IMPUTE77,78 or MACH79 were adopted for imputation. 578 
A detailed description regarding genotyping platforms and imputation procedures have been 579 
outlined (Supplementary Table 2). Stringent quality control of genotype data was applied in 580 
each cohort from CREAM. Samples with low call rates (<95%) or with gender discrepancies 581 
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were excluded. Cryptically related samples and outliers in population structure from principal 582 
component analyses were also excluded. SNPs flagged with missingness >5%, gross 583 
departure from Hardy-Weinberg equilibrium (P <10-6), and minor allele frequency (MAF) 584 
<1% were removed from further analyses. Poorly imputed markers (IMPUTE info <0.5 or 585 
minimac Rsq < 0.5) were excluded. UK Biobank genotyping arrays were imputed to the HRC 586 
reference panel and a combined 1000 Genomes Project –UK10K reference panel using 587 
IMPUTE480. Data quality control (QC) was described in the Supplementary Notes.  588 
 589 
Statistical analyses and meta-analyses 590 
We assumed an additive genetic model where the dosage of each SNP was a continuous 591 
variable ranging from 0 to 2 for the effect allele. For each study, an additive allele-dosage 592 
regression model, adjusted for both age and sex at each genotyped or imputed SNP, was 593 
conducted to determine its association with CC represented as a quantitative trait. An 594 
additional adjustment for up to the first five principal components was carried out according 595 
to the population substructure in each individual study. For studies that included children and 596 
adolescent participants, GWAS analyses were conducted separately by age groups (age ≥ 25 597 
vs. age <25), as for previous GWAS analyses for corneal astigmatism 81. Sample outliers 598 
with CC values exceeding 6 standard deviations from the mean were excluded at the study 599 
level. The per-SNP meta-analyses were performed in METAL software 600 
(https://genome.sph.umich.edu/wiki/METAL) with a weighted inverse-variance approach.82 601 
A Cochran’s Q test was used to assess heterogeneity across studies.83 602 
 603 
Locus identification and genetic variants annotation 604 
The independent signal from the meta-analysis was determined using LD-clumping 605 
procedure in PLINK (https://www.cog-genomics.org/plink2). The index variant was 606 
identified (P < 5 × 10-8) in each clump which was formed for variants with P < 1 × 10-5 that 607 
were in LD (r2 > 0.1) and within 500kb of the index variant. The same variant were assigned 608 
to no more than one clump. The LD structure was estimated from the European panel in the 609 
1000 Genome Project as the reference population, or Asian panel for meta-analysis summary 610 
statistics in Asians. A locus was identified by an index variant with the regions flanking 250 611 
kb on both sides. For those with multiple signals in one locus (500 kb region) or an 612 
overlapping of multiple loci identified from the PLINK clumping procedure, conditional 613 
analysis was further performed to confirm the independent signals using GCTA-COJO84. The 614 
LD structure was estimated in the same manner as for LD-clumping procedure in PLINK. 615 
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The regional plot was drawn for each identified locus from the combined meta-analysis 616 
(Supplementary Figure 4) using LocusZoom (http://locuszoom.org/).  617 
  618 
The coordinates and variant identifiers are reported on the NCBI B37 (hg19) genome build, 619 
and annotated using UCSC Genome Browser85. We identified variants within each of the LD 620 
blocks (r2 ≥ 0.6) in European and Asian populations of the 1000 Genomes Project (100 Kb 621 
flanking the top SNP at each locus) to apply functional annotations of transcription regulation 622 
using HaploReg86 (https://pubs.broadinstitute.org/mammals/haploreg/haploreg_v3.php) and 623 
Encyclopedia of DNA Elements (ENCODE) 87 data.  624 
 625 
Replication in UK Biobank participants 626 
The UK Biobank reported the maximum and minimum corneal power in each eye. After 627 
taking the mean of replicate readings, the corneal power in each eye was calculated as the 628 
mean of the maximum and minimum values. Corneal power was converted to corneal radius 629 
of curvature using the equation CC = (337.5/corneal power). For the genetic analysis of CC 630 
in all available participants, we took the average CC of the 2 eyes as the phenotype. A total of 631 
88,218 individuals were included in the analysis for CC in all available participants. Analyses 632 
were performed using BOLT v2.324. Variant genotype, age, sex, genotyping array (coded as 0 633 
or 1 for the UK BiLEVE or UK Biobank Axiom, respectively) and the first 10 PCs were 634 
included as covariates. BOLT uses a mixed model to account for relatedness (kinship) 635 
between individuals. 636 
 637 
Gene-based tests and pathway analyses 638 
Gene-based testing was conducted using the VEGAS software28,29 639 
(https://vegas2.qimrberghofer.edu.au/) on the results of separate meta-analyses of GWAS in 640 
European and Asian ancestries. Gene-based p-values from different populations were 641 
combined by Fisher’s method. For samples of European descent, we used the European panel 642 
in the 1000 Genome Project as the reference population to estimate patterns of LD. For the 643 
Asian ancestry groups, we used the combined 1000 Genome Project Asian samples as the 644 
reference population to approximate LD patterns. To include gene regulatory regions, SNPs 645 




VEGAS-Pathway analysis 28,29,88 was carried out with pre-specified pathways from Gene 648 
Ontology,89 MSigDB90 (containing canonical pathways and gene-sets from BIOCARTA, 649 
REACTOME, KEGG databases), PANTHER,91 and pathway commons databases92. We 650 
filtered these gene-sets to include only pathways with 10 to 1,000 genes, yielding 9,734 651 
pathways. Empirical VEGAS-Pathway p values for each pathway were computed by 652 
comparing the summed χ2 test statistics from real data with those generated in 500,000 653 
simulations where the relevant number (according to the size of the pathway) of randomly 654 
drawn χ2 test statistics was summed. To ensure that clusters of genes did not adversely affect 655 
results within each pathway, gene sets were pruned such that each gene was >500 kb away 656 
from all other genes in the same pathway. We performed meta-analysis on the two sets of 657 
pathway p-values from Asian and European samples by Fisher’s method.  658 
 659 
We investigated functional annotation of the top identified genes using g:Profiler 660 
(https://biit.cs.ut.ee/gprofiler/gost). For g:Profiler, we used “g:GOST” function to perform 661 
pathway analysis on identified CC-associated genes. Pre-specified pathways include Gene 662 
Ontology, pathways from KEGG, Reactome, WikiPathways and protein complexes 663 
from CORUM93. The significant pathway was claimed at the adjusted p-value < 0.05 after 664 
correction for multiple testing.  665 
 666 
To investigate the connection between the enriched gene sets, we mapped these gene sets into 667 
network functional enrichment map analysis30. We visualize the network enrichment in 668 
Cytoscape software v3.7.1 (https://cytoscape.org/)31. Highly similar gene sets were placed 669 
close together with the interconnectivity among gene sets drawn by line (edge; similarity 670 
coefficient >0.375). 671 
 672 
Association of corneal curvature loci with axial length and spherical equivalent 673 
For all identified CC-associated variants, we assessed their association with refractive error in 674 
European participants of UK Biobank (N = 95,505). We further assessed the association of 675 
CC-associated variants with AL using a subset of CREAM cohorts (N = 10,851; 676 
Supplementary Table 5). False discovery rates (FDR) from the Benjamini-Hochberg 677 
procedure were set at 1% as a threshold of statistical significance26. We categorized CC 678 
variants into three groups: A) variants were associated with AL, but not spherical equivalent; 679 
B) variants were associated with spherical equivalent, and C) variants were not associated 680 




Pleiotropic effect ratio 
βAL
βCC  at each variant was calculated to quantify relevant genetic effects 683 
on AL versus effects on CC and the variance was calculated using Delta method. To estimate 684 
the pleiotropic effect ratio for variants in each group, we performed meta-analyses in 685 
METAL software (https://genome.sph.umich.edu/wiki/METAL) with a weighted inverse-686 
variance approach.82 A Cochran’s Q test was used to assess heterogeneity across variants.83 687 
Z-statistics were used to test the significant difference of the pleiotropic ratio 
βAL
βCC . 688 
 689 
 690 
SNP-Heritability estimation  691 
We applied the LD score method 24 (https://github.com/bulik/ldsc) using GWAS summary 692 
statistics to estimate SNP-h2. After merging SNPs with the HapMap3 Asian samples, we had 693 
a total of 1,174,487 and 1,085,659 SNPs for the LD score regression analyses for the 694 
European and Asian populations, respectively. The LD score matrix was estimated from the 695 
1000 Genomes Project Asian reference panel, or European reference panel separately, with a 696 
1 cM sliding window. We calculated the heritability using the software Idsc v1.0.0. The 697 
resulting regression slope was multiplied by the number of effective SNPs in the reference 698 
panel from the 1000 Genomes Project data24.  699 
 700 
Gene expression in human ocular tissues 701 
To assess gene expression in human tissues, we examined the Ocular Tissue Database 702 
(OTDB) and the EyeSAGE database94,95. The estimated gene and exome level abundances 703 
are available online [AU QUERY: Please provide URL]. Normalization of gene expression 704 
used the PLIER method with GC-background correction94. Relationships between genotype 705 
and cis regulation of gene expression levels were assessed using expression quantitative trait 706 
locus (eQTL) associations obtained from GTEx Portal database96 707 
(https://gtexportal.org/home/).  708 
 709 
Data availability 710 
The summary statistics of the meta-analysis combining studies in CREAM   are included in 711 
Supplementary Data 8. To protect the privacy of the participants in our cohorts, the datasets 712 
generated during and/or analysed during the current study are available from the 713 
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Figure Legends 737 
Figure 1. Manhattan plot of trans-ethnic GWAS meta-analysis for corneal curvature  738 
Both directly genotyped and imputed variants were meta-analysed for corneal curvature in 739 
44,042 CREAM participants. The y axis represents -log10p values for association with 740 
corneal curvature, and the x axis represents genomic position based  on human genome build 741 
37, highlighting newly identified loci (arrows in blue; Table 1), loci associated with axial 742 
length (labelled with nearest gene names), and loci associated with spherical equivalent 743 
(cross in green). The horizontal red line indicates the genome-wide significance level of P 744 
<5.0 x10-8. The horizontal blue line indicates the suggestive significance level of P <1.0 x 10-745 
5.  746 
 747 
Figure 2. Concordance of effect sizes of variants between European and Asian populations 748 
and loci showing population-specific signals. a-c: For each scatter plot, effect size in Asians 749 
(x axis) and in Europeans (y axis) was plotted for variants with P < 0.01 in both ancestry 750 
groups in CREAM. The variants were grouped based on the allele frequency difference 751 
between European and Asian populations: a) < 0.1; b) 0.1-0.3 and d) > 0.3. The red dot 752 
represents variants with P < 1.0 x10-7 in the meta-analysis of combined population, and green 753 
circle indicates variant with 1.0 x10-7 < P < 0.01 in both Europeans and Asians. Dashed line 754 
in red is the fitted line and in grey is the x = y line of unity. d-i: Regional plots in CREAM 755 
Europeans (d, e & f) and Asians (g, h & i) showing population-specific signals at loci 756 
exhibiting allele frequency differences: HDAC11/FBLN2 (d, g), CMPK1/STIL (e, h) and c) 757 
FGF9 (f, i).  Here we present regional plots for three lead variants. i) Lead variant rs2630445 758 
in plot d showing genome-wide association signals in Europeans (MAF=0.10) is 759 
monomorphic in Asian populations.  ii) Lead variant rs60078183 in plot h exhibiting 760 
association in Asians (MAF = 0.21) is monomorphic in European populations. iii) Lead 761 
variant rs9506725 in plot f showing association in Europeans (MAF = 0.36) is monomorphic 762 
in Asian populations. 763 
 764 
Figure 3. Effect sizes on cornea curvature, axial length and spherical equivalent for CC-765 
associated variants. Corneal curvature (CC)-associated genetic variants identified from 766 
CREAM ( n = 44,042) were grouped based on the patterns of the associations of effect alleles 767 
with axial length (AL; n = 10,851) and spherical equivalent (n = 95,505). Group A – variants 768 
associated with AL only (‘eye-size’ determining genetic variants); the effect allele of each 769 
variant was associated with eye size: a larger eye with both a flatter CC and longer AL 770 
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(positive β on both CC and AL; bar in red), and a smaller eye with both a steeper CC and 771 
shorter AL (negative β; bar in blue). These variants were not associated with spherical 772 
equivalent. Group B – variants associated with spherical equivalent; the allele associated with 773 
a steeper CC was associated with a more negative refractive error (or vice versa). These 774 
variants were not associated with AL, except those at loci IGFBP5/TNP1, HUS1, RP11-775 
91P17.1 and FGF9.  Group C – variants not associated with spherical equivalent or AL. For 776 
the associations with axial length and spherical equivalent, FDR < 0.01 was considered 777 
significance. The colour of the bar represents a positive genetic effect (in red) or a negative 778 
genetic effect (in blue).   779 
  780 
Figure 4. Illustration of pleiotropic effect ratio 
βAL
βCC  and effects toward emmetropic and 781 
myopic states.  782 
The figure illustrates genetic effects of AL (βAL) might or might not compensate genetic 783 
effects of corneal curvature (βCC ) toward myopia or hyperopia. Longer CC (shown by 784 
positive βCC; arrow upward) tends to make the eye hyperopic (dashed line in blue) and longer 785 
AL (positive βCC ; arrow downward) tends to make the eye more myopic  (dashed line in red). 786 
Similarly, steeper CC (negative βCC, arrow downward) tends to make the eye more myopic 787 
and shorter AL (negative βCC ; arrow downward) tends to make the eye less myopic. The 788 
compensatory pleiotropic effects βAL  could offset βCC  on myopia or hyperopia at the 789 
pleiotropic ratio 
βAL
βCC  ~ 3, as shown in group A. The compensatory pleiotropic effects βAL 790 
however can’t offset βCC  on myopia or hyperopia at smaller pleiotropic ratio 
βAL
βCC, as shown in 791 
group B.  There might be other pleiotropic effect in Group C, besides AL, to compensate 792 
genetic effect of CC on myopia. Het-I2, for heterogeneous effects between the variants. All P-793 
value for heterogeneity was > 0.05. Pleiotropic effect ratio was calculated at each variant and 794 
combined to estimate 
βAL
βCC  and heterogeneity using the meta-analysis approach (see Methods). 795 
Grouping of A, B and C was the same as in Figure 3. 796 
 797 
Figure 5. Gene-set enrichment analysis for corneal curvature in CREAM data 798 
Enrichment results were mapped as a network of gene sets (nodes) related by mutual overlap 799 
(edges). Node size is proportional to the total number of genes in each set, colour gradient 800 
represents the enrichment significance and edge thickness represents the number of 801 
overlapping genes between sets. Nodes in red represent gene sets identified from the 802 
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g:Profiler enrichment analysis, and in green represent additional gene sets identified from the 803 
VEGAS pathway analysis. Nodes of diamond show the pathways for the implicated genes 804 
associated with both CC and spherical equivalent (Group 2 in Figure 3). Groups of 805 
functionally related gene sets are circled and labelled (dashed line).    806 
  807 
27 
 
Table 1. Summary of SNPs associated with corneal curvature in CREAM populations (P < 5.0 x10-8), with replication in UK Biobank data  8 
 9 
 0 
CREAM-eur CREAM-asn CREAM UK Biobank All  
(n = 29,580) (n = 14,462)  (n = 44,042) (n=88,218) combined 
SNP CHR POS GENE(S) A1/A2 EAF β P EAF β P β P Het-I2 het-P Freq β P Het-I2 P 
rs3737611 1 11186897 MTOR A/G 0.98 -0.040 2.08E-05 0.83 -0.041 6.73E-21 -0.041 2.50E-23 0.00 0.523 0.98 -0.041 1.30E-23 0.00 1.36E-46 
rs4074961 1 38092723 RSPO1 T/C 0.43 0.024 5.83E-22 0.46 0.019 4.10E-10 0.022 1.06E-29 16.20 0.206 0.44 0.022 1.40E-73 0.00 6.51E-100 
rs60078183a 1 47857307 CMPK1/STIL A/G 0.00 NA NA 0.21 -0.037 3.82E-15 -0.037 3.59E-14 0.00 0.694 0.00 -0.034 4.80E-01 0.00 4.47E-16 
rs945170 1 62867483 USP1 T/G 0.27 -0.018 5.11E-12 0.33 -0.007 2.91E-02 -0.014 1.61E-11 27.74 0.067 0.26 -0.012 1.10E-19 0.00 2.64E-30 
rs1548942 2 217619036 IGFBP5/TNP1 T/C 0.15 0.016 5.62E-07 0.19 0.016 1.05E-04 0.016 4.23E-10 0.00 0.757 0.15 0.021 6.40E-37 3.76 5.14E-50 
rs2245601 2 233390937 CHRND/RPSS56 A/G 0.49 -0.014 5.27E-09 0.38 -0.013 2.95E-04 -0.014 1.10E-11 0.00 0.641 0.52 -0.015 5.40E-38 0.00 1.29E-48 
rs2630445a 3 13554886 HDAC11/FBLN1 T/G 0.10 0.030 1.17E-15 0.00 NA NA 0.030 1.17E-15 0.00 0.578 0.10 0.031 8.80E-55 0.00 4.92E-67 
rs485554 3 172137343 FNDC3B/GHSR C/G 0.31 -0.015 1.78E-08 0.49 -0.009 5.08E-03 -0.012 1.01E-09 25.11 0.094 0.32 -0.012 1.60E-19 0.00 2.12E-27 
rs10663094 3 181363464 SOX2 ACT/A 0.34 0.011 1.48E-05 0.41 0.013 8.88E-05 0.012 9.82E-09 1.94 0.435 0.35 0.012 9.70E-23 0.00 1.27E-30 
rs16896276 4 18015156 LCORL A/T 0.27 0.014 1.28E-07 0.38 0.014 2.02E-04 0.014 1.74E-10 0.00 0.951 0.26 0.013 5.70E-21 0.00 1.19E-31 
rs1800813 4 55094467 PDGFRA A/G 0.21 -0.022 9.90E-15 0.23 -0.024 2.19E-10 -0.023 6.44E-23 36.64 0.019 0.22 -0.020 5.80E-45 0.41 1.59E-73 
rs7657200 4 73473151 ADAMTS3 A/G 0.38 0.016 1.48E-09 0.37 0.008 2.20E-02 0.013 6.50E-10 0.00 0.873 0.39 0.014 3.70E-29 0.00 2.23E-38 
rs6831679 4 128113424 RP11-125O18.1 A/G 0.27 0.013 2.80E-07 0.40 0.013 4.42E-05 0.013 9.78E-11 0.00 0.808 0.28 0.008 3.50E-10 3.57 1.14E-18 
rs11740254 5 64319640 CWC27/ADAMTS6 T/C 0.40 0.014 2.48E-07 0.27 0.010 1.15E-02 0.013 1.55E-08 0.00 0.827 0.46 0.011 6.70E-21 0.00 4.96E-30 
rs13180294 5 79360175 THBS4 A/G 0.08 -0.028 1.17E-10 0.05 -0.018 6.68E-02 -0.027 3.37E-11 0.00 0.479 0.10 -0.015 7.50E-14 6.85 2.46E-22 
rs7708378a 5 129088784 ADAMTS19/CHSY3 T/G 0.07 0.028 2.49E-09 0.00 NA NA 0.028 2.49E-09 0.00 0.474 0.08 0.028 2.80E-34 0.00 5.51E-45 
rs67612840 6 10028826 OFCC1 A/T 0.28 -0.012 3.34E-06 0.26 -0.015 2.42E-05 -0.013 8.26E-10 4.24 0.398 0.27 -0.014 6.40E-26 0.00 4.11E-35 
rs9366426 6 22064639 CASC15 T/C 0.44 0.014 2.11E-08 0.78 0.012 4.00E-03 0.013 4.42E-10 26.55 0.081 0.43 0.013 9.30E-28 0.00 5.39E-37 
rs961755 6 113443139 U6 T/G 0.20 0.011 1.91E-04 0.33 0.014 1.32E-05 0.013 2.49E-08 0.00 0.844 0.18 0.014 2.30E-21 0.00 1.49E-30 
rs4620141 6 138869568 NHSL1 T/C 0.36 -0.013 2.90E-07 0.58 -0.015 3.35E-06 -0.014 1.12E-11 19.17 0.164 0.36 -0.008 5.10E-11 5.93 1.74E-20 
rs12702376 7 47775053 HUS1 C/G 0.84 -0.028 9.25E-18 0.86 -0.024 9.69E-03 -0.028 3.52E-19 12.45 0.286 0.85 -0.029 2.40E-67 0.00 2.77E-86 
rs7004112 8 78941331 RP11-91P17.1 T/G 0.40 -0.010 3.08E-05 0.50 -0.017 1.82E-08 -0.013 4.20E-11 6.85 0.353 0.37 -0.014 1.10E-28 0.00 6.39E-38 
rs4837104 9 129433929 LMX1B A/G 0.05 0.024 1.43E-04 0.27 0.021 4.29E-07 0.022 7.35E-10 0.00 0.956 0.04 0.022 1.90E-12 0.00 2.73E-24 
rs3132309 9 137433436 COL5A1 A/C 0.42 -0.015 3.52E-08 0.44 -0.011 7.98E-04 -0.014 2.27E-10 0.00 0.550 0.41 -0.013 3.10E-24 0.00 7.00E-35 
rs11204213a 10 48388228 RBP3 T/C 0.00 NA NA 0.04 0.071 9.83E-13 0.071 9.83E-13 0.00 0.741 0.00 0.063 1.50E-01 0.00 4.36E-13 
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rs166976 10 90024599 RNLS A/G 0.72 -0.018 1.26E-10 0.80 -0.012 1.45E-03 -0.016 2.47E-12 5.52 0.378 0.73 -0.015 3.80E-30 0.00 4.17E-44 
rs10786330 10 99074959 FRAT1/FRAT2/ARHGAP19 A/C 0.58 0.012 2.47E-06 0.65 0.013 6.11E-05 0.012 1.22E-09 0.00 0.980 0.60 0.008 4.00E-12 1.93 1.54E-19 
rs807037 10 102824349 KAZALD1 C/G 0.67 -0.014 4.33E-08 0.49 -0.017 2.02E-07 -0.015 1.43E-13 0.00 0.631 0.66 -0.017 9.10E-42 0.00 7.12E-54 
rs7948458 11 2172830 IGF2 A/C 0.20 -0.014 9.53E-06 0.51 -0.015 5.33E-06 -0.014 4.90E-10 40.44 0.008 0.19 -0.016 6.50E-26 0.00 1.66E-36 
rs11181913 12 43574200 ADAMTS20 A/G 0.90 0.020 2.02E-06 0.92 0.018 3.50E-03 0.019 3.30E-08 0.00 0.645 0.91 0.016 4.40E-14 0.00 1.03E-22 
rs7959830 12 66347368 HMGA2 T/G 0.42 -0.020 2.53E-16 0.80 -0.009 5.66E-02 -0.018 3.02E-16 34.50 0.027 0.42 -0.018 3.30E-17 5.41 9.35E-47 
rs9506725a 13 22314146 FGF9 T/C 0.64 0.019 3.07E-14 1.00 NA NA 0.019 3.07E-14 0.33 0.456 0.63 0.020 5.10E-59 0.00 1.21E-78 
rs9316971 13 22980191 SNORD36 T/C 0.28 -0.015 2.43E-07 0.48 -0.010 1.63E-03 -0.013 3.21E-09 32.34 0.044 0.29 -0.009 2.20E-12 1.91 3.51E-21 
rs7327381 13 52006645 INTS6 T/C 0.40 0.015 2.16E-09 0.53 0.013 4.27E-05 0.014 8.06E-13 0.00 0.829 0.41 0.012 1.50E-23 0.00 3.74E-34 
rs75772222 14 25447080 STXBP6 T/C 0.11 0.021 3.21E-08 0.07 0.024 4.55E-05 0.021 1.28E-11 0.00 0.983 0.11 0.020 5.00E-27 0.00 9.79E-38 
rs4083463 14 81856323 STON2 A/G 0.31 0.012 1.91E-06 0.34 0.011 7.14E-04 0.012 7.92E-09 4.26 0.397 0.33 0.010 2.00E-16 0.00 3.12E-24 
rs9806595 15 48755168 FBN1 T/C 0.77 -0.009 1.68E-03 0.67 -0.018 1.49E-07 -0.012 2.23E-08 0.00 0.691 0.77 -0.004 4.20E-03 10.40 6.43E-09 
rs4887113 15 79095287 ADAMTS7 T/C 0.40 0.016 3.08E-09 0.18 0.021 1.21E-03 0.016 2.57E-11 0.00 0.798 0.45 0.012 1.60E-24 2.11 5.74E-38 
rs184926585 18 32643292 MAPRE2 T/C 0.93 -0.020 2.19E-05 0.82 -0.021 2.63E-04 -0.020 3.61E-08 0.00 0.756 0.92 -0.007 1.30E-03 11.53 4.86E-11 
rs6064518 20 55821046 BMP7 T/G 0.33 0.017 4.85E-11 0.16 0.021 1.11E-03 0.017 3.47E-13 0.00 0.809 0.32 0.013 1.20E-24 2.15 6.73E-40 
rs13050142 21 47427165 COL6A1 T/C 0.29 -0.016 1.71E-08 0.22 -0.022 9.43E-05 -0.017 1.86E-11 0.00 0.964 0.31 -0.013 4.80E-25 1.87 2.45E-40 
Lead variants shown were genome-wide significant (P < 5.0E-8) in subjects of CREAM of European and Asian ancestry (Stage 1), with results of replication in UK 1 
Biobank data (Stage 2). Variants in bold indicate new loci.  2 
SNP, single-nucleotide polymorphism; Chr, chromosome; Nearest gene in 200kb flanking the lead SNP based on NCBI build 37; A1, effect allele; A2, reference 3 
allele; EAF, effect allele frequency; β, effect size of corneal curvature in millimeter based on the effect allele A1; Het-I2:heterogeneous effects I2 (%) between the 4 
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